Table 1 The basic information of cases and controls
From: Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
Variable | Cases (n = 351) | Controls (n = 344) | p |
|---|---|---|---|
Age (Mean ± SD) | 55.66 ± 8.46 | 55.60 ± 8.43 | 0.923 |
≤ 55 | 184 | 178 | |
> 55 | 167 | 166 | |
Clinical index | |||
CEA | 305 | 105 | |
Quantity in serum(ng/ml) | 12.55 ± 3.95 | 2.24 ± 3.14 | < 0.001* |
CA125 | 299 | 105 | |
Quantity in serum (U/ml) | 24.23 ± 56.30 | 13.25 ± 11.52 | 0.048* |
CA199 | 285 | 95 | |
Quantity in serum (U/ml) | 21.21 ± 58.23 | 13.91 ± 11.62 | 0.226 |
AFP | 303 | 105 | |
Quantity in serum (ng/ml) | 9.75 ± 5.28 | 2.77 ± 0.97 | < 0.001* |